State Street’s Genmab GMAB Stock Holding History

State Street’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-80,264	Closed	-$3.03M	–	4698
2023 Q1	$3.03M	Sell	80,264 -22,510	-22%	-$865K	﹤0.01%	3173
2022 Q4	$4.36M	Buy	+102,774	New	+$4.23M	﹤0.01%	3091
2022 Q3	–	Sell	-45,652	Closed	-$1.48M	–	4941
2022 Q2	$1.48M	Sell	45,652 -161,210	-78%	-$5.22M	﹤0.01%	3549
2022 Q1	$7.48M	Buy	206,862 +43,524	+27%	+$1.49M	﹤0.01%	2982
2021 Q4	$6.46M	Buy	163,338 +149,659	+1,094%	+$6.24M	﹤0.01%	3123
2021 Q3	$598K	Sell	13,679 -14,417	-51%	-$647K	﹤0.01%	3911
2021 Q2	$1.15M	Buy	28,096 +8,839	+46%	+$341K	﹤0.01%	3637
2021 Q1	$632K	Sell	19,257 -45,085	-70%	-$1.7M	﹤0.01%	3705
2020 Q4	$2.62M	Sell	64,342 -30,739	-32%	-$1.15M	﹤0.01%	3259
2020 Q3	$3.48M	Buy	+95,081	New	+$3.44M	﹤0.01%	2965
2020 Q2	–	Sell	-40,089	Closed	-$849K	–	3835
2020 Q1	$849K	Buy	+40,089	New	+$894K	﹤0.01%	3344

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street's GMAB Position: Q2 2023 in Review

State Street sold out of Genmab (GMAB) in Q2 2023, closing a stake of 80,264 shares — an estimated $3.03M sold.

State Street first reported a position in GMAB in Q1 2020 and held it in 11 quarters. The position peaked at $7.48M in Q1 2022. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2023.

State Street reported no remaining Genmab position as of Q2 2023 after selling out during the quarter.
State Street sold 80,264 Genmab shares in Q2 2023, an estimated $3.03M.
State Street first reported a position in Genmab in Q1 2020 and held it in 11 quarters.
State Street's Genmab position peaked at $7.48M in Q1 2022.
213 funds tracked by Wall St. Rank held Genmab as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.